Bayer's Skyla Cleared in the US - Analyst Blog
15 January 2013 - 4:35AM
Zacks
The HealthCare unit of Bayer AG (BAYRY)
received encouraging news from the US Food and Drug Administration
(FDA), which recently approved Bayer’s low dose
levonorgestrel-releasing intrauterine system (IUS) known as Skyla.
Skyla helps in preventing pregnancy for up to three years when
placed in the uterus.
Skyla’s approval provides women with a reliable option in case
they want to avoid taking pills. Moreover, the new IUS allows a
rapid return to a women’s usual level of fertility after removal.
Skyla’s approval will add on to Bayer’s wide range of birth control
products.
Meanwhile, in Dec 2012, Bayer successfully completed its
registration procedure in the EU for its new IUS system. The
product is expected to be marketed in the EU under the trade name
of Jaydess.
We note that companies like Warner Chilcott
(WCRX) have a presence in the birth control products market.
The HealthCare unit of Bayer was recently in the news for
receiving the necessary regulatory approval from the Federal Trade
Commission for the completion of its acquisition of Teva
Pharmaceutical Industries Limited’s (TEVA) animal health
unit in the US.
Moreover, the HealthCare unit of Bayer announced earlier this
month that a phase III trial (DECISION: n=417) of Nexavar
(sorafenib), co-developed and marketed with Onyx
Pharmaceuticals Inc. (ONXX) met its primary endpoint.
We currently have a Neutral recommendation on Bayer. The stock
carries a Zacks Rank #2 (Buy). Other large-cap pharma stocks such
as Novartis AG (NVS) and Eli Lilly and
Company (LLY) also carry a Zacks #2 Rank (Buy).
BAYER A G -ADR (BAYRY): Free Stock Analysis Report
LILLY ELI & CO (LLY): Free Stock Analysis Report
NOVARTIS AG-ADR (NVS): Free Stock Analysis Report
ONYX PHARMA INC (ONXX): Free Stock Analysis Report
TEVA PHARM ADR (TEVA): Free Stock Analysis Report
WARNER CHIL PLC (WCRX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024